Inscripta, founded in 2015 in Finland, is at the forefront of using AI-powered speech recognition to enhance healthcare documentation. The company focuses on the Big Data, Internet, and Machine Learning industries, providing innovative solutions that make medical documentation more efficient and accurate.
The proprietary AI technology developed by Inscripta facilitates seamless dictation directly into patient information systems through its premier solution, Inscripta Direct. This advancement saves healthcare professionals an average of 45 minutes daily, contributing to improved patient care and resource management.
The company prioritizes trust, collaboration, quality, and ease of use, aligning with its mission to support healthcare professionals in delivering better care. Inscripta last secured a €700.00K angel investment on 01 May 2021 from investors including Ali Omar, Leena Niemistö, Henry Nilert, and Jari Paakkarinen, underscoring the confidence and support from key industry figures.